Inimex Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2008
Total raised
- $26M
Investors
- 8
About Inimex Pharmaceuticals
Inimex Pharmaceuticals Inc.Founded in 2001 and headquartered in Burnaby, Canada, Inimex Pharmaceuticals Inc. specializes in creating pharmaceutical solutions.Inimex Pharma specializes in the development and commercialization of innovative pharmaceutical products that address various medical needs. Their core offerings include a range of prescription medications aimed at treating chronic and acute conditions, focusing on infectious diseases and inflammatory disorders. The products are designed to enhance patient outcomes by providing targeted therapeutic solutions. The company serves healthcare providers, hospitals, and clinics reaching both healthcare professionals and end consumers who require advanced treatment options.Inimex Pharma generates revenue through direct sales of their pharmaceutical products to healthcare facilities and practitioners, involving both B2B and B2C transactions. The company utilizes a pricing structure based on individual product offerings, where flagship products command premium pricing due to their innovative nature and efficacy. Clients engage in transactions through negotiated contracts, defining purchase and distribution terms.Inimex Pharmaceuticals Inc. Additionally, they aim to expand their market presence in new geographical regions, specifically targeting deeper market penetration in Asia by the end of 2025.
Who invested in Inimex Pharmaceuticals
8 investors across 2 rounds
See all investors in Inimex Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inimex Pharmaceuticals
Who invested in Inimex Pharmaceuticals?
Inimex Pharmaceuticals has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inimex Pharmaceuticals raised?
Inimex Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Inimex Pharmaceuticals last raise money?
Inimex Pharmaceuticals's most recent round on record is a Series B, in Nov 2008.
What does Inimex Pharmaceuticals do?
Inimex Pharmaceuticals is a biotechnology company.
Where is Inimex Pharmaceuticals headquartered?
Inimex Pharmaceuticals is headquartered in Burnaby, Canada.
Which VCs invest in companies like Inimex Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inimex Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Inimex Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.